We are analyzing https://link.springer.com/article/10.1007/s11095-010-0105-y.

Title:
Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research | Pharmaceutical Research
Description:
In recent years, microRNAs have received greater attention in cancer research. These small, non-coding RNAs could inhibit target gene expression by binding to the 3′ untranslated region of target mRNA, resulting in either mRNA degradation or inhibition of translation. miRNAs play important roles in many normal biological processes; however, studies have also shown that aberrant miRNA expression is correlated with the development and progression of cancers. The miRNAs could have oncogenic or tumor suppressor activities. Moreover, some miRNAs could regulate formation of cancer stem cells and epithelial-mesenchymal transition phenotype of cancer cells which are typically drug resistant. Furthermore, miRNAs could be used as biomarkers for diagnosis and prognosis, and thus miRNAs are becoming emerging targets for cancer therapy. Recent studies have shown that natural agents including curcumin, isoflavone, indole-3-carbinol, 3,3′-diindolylmethane, (-)-epigallocatechin-3-gallate, resveratrol, etc. could alter miRNA expression profiles, leading to the inhibition of cancer cell growth, induction of apoptosis, reversal of epithelial-mesenchymal transition, or enhancement of efficacy of conventional cancer therapeutics. These emerging results clearly suggest that specific targeting of miRNAs by natural agents could open newer avenues for complete eradication of tumors by killing the drug-resistant cells to improve survival outcome in patients diagnosed with malignancies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

article, pubmed, google, scholar, cas, cancer, microrna, cell, expression, res, cells, human, micrornas, wang, prostate, lee, tumor, breast, biol, gene, growth, pancreatic, usa, natural, mirnas, stem, apoptosis, nature, regulation, sarkar, rna, mol, genes, sci, research, agents, curcumin, targeting, clin, zhang, lung, kim, oncogene, proc, natl, acad, small, inhibition, mirna, suppressor,

Topics {✒️}

lieber-decarli diet-induced alcoholic egfr-regulated anti-apoptotic factor month download article/chapter key tumor-suppressive pathways mir-21-mediated tumor growth sonic hedgehog-driven medulloblastomas real-time pcr platform drug-induced liver injury sirna-induced rna silencing androgen receptor-regulated microrna epithelial-mesenchymal transition phenotype targets estrogen receptor-alpha angiogenesis-related genes identified multiple cell-cycle genes death-promoting regulatory loop tumor suppressor microrna tumor suppressor activities stable blood-based markers mir-106a predicts survival myc-activated microrna cluster full article pdf rna polymerase ii small inhibitory rna synthetic microrna-16 inhibits chemopreventive agent indole-3-carbinol sonic hedgehog pathway heterochronic gene lin-14 pancreatic tumor cells micro steering wheel bmc res notes short hairpin rnas cancer stem cells human breast cancer privacy choices/manage cookies therapy-resistant neuroblastoma open newer avenues oral carrier system prostate cancer cells normal stem cells human cancer cells coding rnas karmanos cancer institute gene expression profiles drug-resistant cells drosha-dgcr8 complex iorio mv cytotoxic anticancer therapy tumor-promoting activity epithelial-mesenchymal transition c-myc expression

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research
         description:In recent years, microRNAs have received greater attention in cancer research. These small, non-coding RNAs could inhibit target gene expression by binding to the 3′ untranslated region of target mRNA, resulting in either mRNA degradation or inhibition of translation. miRNAs play important roles in many normal biological processes; however, studies have also shown that aberrant miRNA expression is correlated with the development and progression of cancers. The miRNAs could have oncogenic or tumor suppressor activities. Moreover, some miRNAs could regulate formation of cancer stem cells and epithelial-mesenchymal transition phenotype of cancer cells which are typically drug resistant. Furthermore, miRNAs could be used as biomarkers for diagnosis and prognosis, and thus miRNAs are becoming emerging targets for cancer therapy. Recent studies have shown that natural agents including curcumin, isoflavone, indole-3-carbinol, 3,3′-diindolylmethane, (-)-epigallocatechin-3-gallate, resveratrol, etc. could alter miRNA expression profiles, leading to the inhibition of cancer cell growth, induction of apoptosis, reversal of epithelial-mesenchymal transition, or enhancement of efficacy of conventional cancer therapeutics. These emerging results clearly suggest that specific targeting of miRNAs by natural agents could open newer avenues for complete eradication of tumors by killing the drug-resistant cells to improve survival outcome in patients diagnosed with malignancies.
         datePublished:2010-03-20T00:00:00Z
         dateModified:2010-03-20T00:00:00Z
         pageStart:1027
         pageEnd:1041
         sameAs:https://doi.org/10.1007/s11095-010-0105-y
         keywords:
            cancer therapy
            chemoprevention
            microRNA
            natural agents
            Pharmacology/Toxicology
            Pharmacy
            Biochemistry
            general
            Medical Law
            Biomedical Engineering and Bioengineering
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-010-0105-y/MediaObjects/11095_2010_105_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-010-0105-y/MediaObjects/11095_2010_105_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-010-0105-y/MediaObjects/11095_2010_105_Fig3_HTML.gif
         isPartOf:
            name:Pharmaceutical Research
            issn:
               1573-904X
               0724-8741
            volumeNumber:27
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yiwei Li
               affiliation:
                     name:Wayne State University School of Medicine
                     address:
                        name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dejuan Kong
               affiliation:
                     name:Wayne State University School of Medicine
                     address:
                        name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhiwei Wang
               affiliation:
                     name:Wayne State University School of Medicine
                     address:
                        name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fazlul H. Sarkar
               affiliation:
                     name:Wayne State University School of Medicine
                     address:
                        name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                        type:PostalAddress
                     type:Organization
                     name:Wayne State University School of Medicine
                     address:
                        name:Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research
      description:In recent years, microRNAs have received greater attention in cancer research. These small, non-coding RNAs could inhibit target gene expression by binding to the 3′ untranslated region of target mRNA, resulting in either mRNA degradation or inhibition of translation. miRNAs play important roles in many normal biological processes; however, studies have also shown that aberrant miRNA expression is correlated with the development and progression of cancers. The miRNAs could have oncogenic or tumor suppressor activities. Moreover, some miRNAs could regulate formation of cancer stem cells and epithelial-mesenchymal transition phenotype of cancer cells which are typically drug resistant. Furthermore, miRNAs could be used as biomarkers for diagnosis and prognosis, and thus miRNAs are becoming emerging targets for cancer therapy. Recent studies have shown that natural agents including curcumin, isoflavone, indole-3-carbinol, 3,3′-diindolylmethane, (-)-epigallocatechin-3-gallate, resveratrol, etc. could alter miRNA expression profiles, leading to the inhibition of cancer cell growth, induction of apoptosis, reversal of epithelial-mesenchymal transition, or enhancement of efficacy of conventional cancer therapeutics. These emerging results clearly suggest that specific targeting of miRNAs by natural agents could open newer avenues for complete eradication of tumors by killing the drug-resistant cells to improve survival outcome in patients diagnosed with malignancies.
      datePublished:2010-03-20T00:00:00Z
      dateModified:2010-03-20T00:00:00Z
      pageStart:1027
      pageEnd:1041
      sameAs:https://doi.org/10.1007/s11095-010-0105-y
      keywords:
         cancer therapy
         chemoprevention
         microRNA
         natural agents
         Pharmacology/Toxicology
         Pharmacy
         Biochemistry
         general
         Medical Law
         Biomedical Engineering and Bioengineering
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-010-0105-y/MediaObjects/11095_2010_105_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-010-0105-y/MediaObjects/11095_2010_105_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-010-0105-y/MediaObjects/11095_2010_105_Fig3_HTML.gif
      isPartOf:
         name:Pharmaceutical Research
         issn:
            1573-904X
            0724-8741
         volumeNumber:27
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yiwei Li
            affiliation:
                  name:Wayne State University School of Medicine
                  address:
                     name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dejuan Kong
            affiliation:
                  name:Wayne State University School of Medicine
                  address:
                     name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhiwei Wang
            affiliation:
                  name:Wayne State University School of Medicine
                  address:
                     name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fazlul H. Sarkar
            affiliation:
                  name:Wayne State University School of Medicine
                  address:
                     name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                     type:PostalAddress
                  type:Organization
                  name:Wayne State University School of Medicine
                  address:
                     name:Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Pharmaceutical Research
      issn:
         1573-904X
         0724-8741
      volumeNumber:27
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Wayne State University School of Medicine
      address:
         name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
         type:PostalAddress
      name:Wayne State University School of Medicine
      address:
         name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
         type:PostalAddress
      name:Wayne State University School of Medicine
      address:
         name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
         type:PostalAddress
      name:Wayne State University School of Medicine
      address:
         name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
         type:PostalAddress
      name:Wayne State University School of Medicine
      address:
         name:Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yiwei Li
      affiliation:
            name:Wayne State University School of Medicine
            address:
               name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
               type:PostalAddress
            type:Organization
      name:Dejuan Kong
      affiliation:
            name:Wayne State University School of Medicine
            address:
               name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
               type:PostalAddress
            type:Organization
      name:Zhiwei Wang
      affiliation:
            name:Wayne State University School of Medicine
            address:
               name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
               type:PostalAddress
            type:Organization
      name:Fazlul H. Sarkar
      affiliation:
            name:Wayne State University School of Medicine
            address:
               name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
               type:PostalAddress
            type:Organization
            name:Wayne State University School of Medicine
            address:
               name:Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
      name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
      name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
      name:Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
      name:Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(414)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.22s.

LINK . SPRINGER . COM {}